30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,186 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mid (3.1bn) 0 No activity — 0–15%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 50%+
US CorVel Corp (CRVL)
Healthcare Services Mid (3.0bn) -1–5 -$1M–$10M -0–15% 15–50%
US Heartflow Inc (HTFL)
Healthcare Services Mid (3.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 0–15%
Healthcare Services Mid (3.0bn) 0 No activity — 0–15%
DE MorphoSys AG (MOR)
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 50%+
US Alumis Inc (ALMS)
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 0–15%
US Covetrus Inc (CVET)
Healthcare Services Mid (2.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 50%+
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 15–50%
ES Almirall SA (ALM)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 15–50%
SE Cellink AB (CLNK-B)
Healthcare Services Mid (2.9bn) 0 No activity — 15–50%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 15–50%
Healthcare Services Mid (2.8bn) 0 No activity — 0–15%
Healthcare Services Mid (2.8bn) 0 No activity — 0–15%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (2.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Healthcare Services Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 No activity — 0–15%
Healthcare Services Mid (2.7bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 No activity — 0–15%
FR Emeis SA (EMEIS)
Healthcare Services Mid (2.6bn) 1–5 $100K–$1M 0–15% 0–15%
DE Synlab AG (SYAB)
Healthcare Services Mid (2.6bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (2.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Nanobiotix SA (NANO)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$10M–$100M -0–15% 0–15%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 No activity — 0–15%
US AxoGen Inc (AXGN)
Healthcare Services Mid (2.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Ambu A/S (AMBU-B)
Healthcare Services Mid (2.4bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 0–15%
IN Dr. Lal PathLabs Ltd (LALPATHLAB)
Healthcare Services Mid (2.3bn) -1–5 -< $100K -0–15% 50%+
US Premier Inc (PINC)
Healthcare Services Mid (2.3bn) 0 No activity — 0–15%
NL Pharvaris NV (PHVS)
Pharmaceuticals & Medical Research Mid (2.3bn) -6–10 -$1M–$10M -0–15% 0–15%
IN Poly Medicure Ltd (POLYMED)
Healthcare Services Mid (2.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -< $100K -0–15% 0–15%
IT Amplifon SpA (AMP)
Healthcare Services Mid (2.3bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 15–50%
Healthcare Services Mid (2.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Mid (2.2bn) 1–5 < $100K 0–15% 0–15%
US Vericel Corp (VCEL)
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Healthcare Services Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
US Immunome Inc (IMNM)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
US Progyny Inc (PGNY)
Healthcare Services Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -< $100K -0–15% 0–15%
US Zai Lab Ltd (9688)
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Healthcare Services Small (2.0bn) 0 No activity — 15–50%
Healthcare Services Small (2.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
US Precigen Inc (PGEN)
Pharmaceuticals & Medical Research Small (1.9bn) -6–10 -$10M–$100M -0–15% 0–15%
US Omnicell Inc (OMCL)
Healthcare Services Small (1.9bn) 0 No activity — 0–15%